
Atea Pharmaceuticals, Inc.
USD4.21
-0.06 (-1.41%)
CEO
Jean-Pierre Sommadossi
IPO Date
2020-10-30
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$4.25
Prev. Close
$4.27
Day Low
$4.16
Day High
$4.31
52W Low
$2.78
52W High
$6.45
Market Cap
$0.34B
Volume
0.32M
| 10 Aug 2023 |
| JP Morgan |
| Neutral |
| Underweight |
| downgrade |
| 16 Mar 2023 | JP Morgan | Neutral | Neutral | maintain |
| 27 Jan 2023 | SVB Leerink | Market Perform | Market Perform | maintain |
| 24 Jan 2023 | Morgan Stanley | Underweight | Underweight | maintain |
| 15 Aug 2022 | Morgan Stanley | Underweight | Underweight | maintain |
| 2 Mar 2022 | JP Morgan | Neutral | Neutral | maintain |
| 1 Mar 2022 | SVB Leerink | Market Perform | Market Perform | maintain |